Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
CA 2430918 A1 · Owner: Viaxxel Biotech Gmbh · Inventors: Prechtel, Alexander Thorsten; Hauber, Joachim
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds that specifically block the binding between a member of the HuR family of proteins and a mRNA encoding a member of the CD83 family of proteins and that reduce expression of a member of the CD83 family of proteins in a cell as well as pharmaceutical compositions comprising such compounds and methods for screening and/or identifying compounds that block the binding between a member of the HuR family of proteins and a mRNA encoding a member of the CD83 family of proteins.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 14, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 14, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 14, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.